Prakiraan rega marang bathi: Haleon PLC (HLN)

Logo grafis Haleon Corp (HLN)

A broad portfolio of well-known brands allows Haleon plc (HLN) to effectively index product pricing and maintain margins. Stable demand for hygiene products ensures crisis resilience, which is supported by the business's forward P/E multiple. The current 15.50 captures the market valuation, while strong human capital and specialist loyalty guarantee the company's qualitative development.

HLN - Pangali mangsa ngarep rega marang bathi haleon.com ing rentang 28.04.2023 - 16.11.2026

Rincian metrik keuangan lan pasar Haleon plc (HLN)

- nilai saham lan prakiraan konsensus rega:
- indikator kapitalisasi bursa perusahaan:
Pambiji fundamental:Haleon PLC
Produk mawa merek Haleon Corp

The long-term reliability of Haleon plc is determined by the business's ability to convert future earnings into actual cash flow. The forward P/E ratio relates the current share price to expected earnings, revealing whether the asset is overvalued or undervalued. The trend of the company's forward price-to-earnings ratio visualizes the balance between market expectations and solvency. A decline in this metric may signal debt risks. The stability of this indicator is supported by optimized over-the-counter drug logistics, which minimize distribution costs.

Analisis perusahaan pesaing

Prakiraan rega marang bathi KVUE (Kenvue Corp)|VRNA (Verona Pharma Inc.) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Jyong Biotech Limited MENS|Ligand (LGND) - Rasio prakiraan rega marang bathi|AMRX: Prakiraan rega marang bathi|Perrigo - Rasio kapitalisasi marang bathi mangsa ngarep|ALVO: Pangali Forward P/E|Liquidia Technologies - Pangali mangsa ngarep rega marang bathi|GLPG (Galapagos N.V.) - Pangali Forward P/E|Rasio prakiraan rega marang bathi anipharmaceuticals.com ANIP|Rega marang bathi mangsa ngarep MannKind (MNKD)|AMPH (Amphastar Pharmaceuticals, Inc.) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Pacira BioSciences, Inc. PCRX|Pangali Forward P/E ARS Corp SPRY|Theravance Biopharma - Pangali Forward P/E|Pangali forward rega marang bathi Aquestive Therapeutics, Inc. (AQST)|scPharmaceuticals (SCPH) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Tectonic Therapeutic, Inc.|TNXP (Tonix Pharmaceuticals Holding) - Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep SXTC (China SXT Pharmaceuticals)|Pangali Forward P/E EPRX|Pangali Forward P/E bioharvest.com (BHST)|Rega marang bathi mangsa ngarep Invizyne Technologies EXOZ|ORMP: Rasio rega marang bathi mangsa ngarep|ENTX: Prakiraan rega marang bathi|HYFT: Rega marang bathi mangsa ngarep|ABVC BioPharma Inc. (ABVC) - Rega marang bathi mangsa ngarep|cumberlandpharma.com (CPIX) - Pangali Forward P/E|QNTM (Quantum BioPharma) - Pangali Forward P/E|FGEN: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E TELO|Pangali Forward P/E Rani Therapeutics Holdings (RANI)|Pangali Forward P/E SNYR (Synergy CHC Corp)|Rallybio Corporation (RLYB) - Rasio prakiraan rega marang bathi|LEXX - Rega marang bathi mangsa ngarep|PULM (Pulmatrix) - Rasio rega marang bathi mangsa ngarep|Pheton Holdings Ltd (PTHL) - Rega marang bathi mangsa ngarep|Aptorum - Pangali mangsa ngarep rega marang bathi|Prakiraan rega marang bathi LYRA|Prakiraan rega marang bathi Impact BioMedical Inc (IBO)|Pangali Forward P/E TNFA|YCBD: Rasio rega marang bathi sing dikarepake|Rega marang bathi mangsa ngarep PainReform PRFX|altamiratherapeutics.com (CYTO) - Rasio prakiraan rega marang bathi|LIPO: Prakiraan rega marang bathi|OPTN (optinose.com) - Rasio rega marang bathi mangsa ngarep|PIRS: Pangali Forward P/E|PROC - Kapitalisasi marang proyeksi bathi|PTPI (Petros Pharma) - Pangali Forward P/E|Rega marang bathi mangsa ngarep QLI|Pangali Forward P/E SLRN|Rasio kapitalisasi marang bathi mangsa ngarep TFFP